ECG-Guided Umbilical Vessel Catheterization for Acute Lymphoblastic Leukemia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to make umbilical venous catheter (UVC) placement safer for newborns with acute lymphoblastic leukemia. Researchers plan to use ECG, a test that checks heart activity, to guide and monitor catheter placement more accurately. The goal is to prevent the catheter from accidentally entering areas like the liver or spleen, which can be harmful. This trial targets newborns weighing between 2 to 6 kg who need or already have a UVC. As an unphased trial, it offers a unique opportunity to contribute to safer medical procedures for newborns.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that ECG-guided umbilical vessel catheterization is safe for neonatal patients?
Research has shown that ECG (electrocardiogram) monitoring can enhance the safety of umbilical vessel catheterization. This method improves catheter placement accuracy, reducing the risk of incorrect positioning in areas like the liver or spleen, which can be harmful.
Umbilical vessel catheterization, used to administer medicines and fluids to newborns, is generally safe and effective. Although specific data on side effects when using ECG for guidance is lacking, this method aims to improve safety by ensuring correct catheter positioning.
Overall, ECG-guided catheter placement is considered a promising approach to making this important procedure safer for infants.12345Why are researchers excited about this trial?
Researchers are excited about using ECG-guided umbilical vessel catheterization for treating neonatal patients with acute lymphoblastic leukemia because it offers a more precise method of catheter placement. Unlike traditional techniques that rely on anatomical landmarks or X-ray guidance, this approach uses real-time ECG monitoring to ensure accurate catheter positioning. This precision can potentially reduce complications and improve the effectiveness of the treatment, making it a promising development in the care of these young patients.
What evidence suggests that ECG-guided umbilical vessel catheterization is effective for acute lymphoblastic leukemia?
Research has shown that using an electrocardiogram (ECG) to guide catheter placement in umbilical vessels improves accuracy. In this trial, participants will receive ECG monitoring to ensure correct placement of umbilical vessel catheters. Traditional methods sometimes lead to incorrect placement, causing complications. ECG monitoring helps place the catheter accurately, reducing the risk of dangerous placement in areas like the liver or spleen. Early findings suggest that ECG-guided placement offers a safer and more reliable method for newborns needing this procedure. Overall, this approach aims to enhance safety and effectiveness in critical infant care.12345
Are You a Good Fit for This Trial?
This trial is for newborn pediatric patients who weigh between 2 to 6 kilograms and either require or currently have an umbilical venous catheter (UVC). To participate, they must have consent from parents. Clinically unstable infants cannot take part in this study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
ECG readings are collected for neonatal patients with UVC to monitor catheter placement
Follow-up
Participants are monitored for safety and effectiveness after ECG monitoring
What Are the Treatments Tested in This Trial?
Interventions
- ECG
- Umbilical Vessel Catheterization
Trial Overview
The study is testing the use of electrocardiogram (ECG) monitoring as a non-invasive method to place and continuously monitor the position of UVCs in neonates, aiming to reduce misplacement risks associated with traditional methods.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
ECG readings will be collected for neonatal patients who require or currently have UVC
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
Citations
1.
withpower.com
withpower.com/trial/ecg-guided-umbilical-vessel-catheterization-for-acute-lymphoblastic-leukemia-dad17ECG-Guided Umbilical Vessel Catheterization for Acute ...
This N/A medical study run by Stanford University is evaluating whether Umbilical Vessel Catheterization will have tolerable side effects & efficacy for ...
2.
clinicaltrial.be
clinicaltrial.be/en/details/64441?per_page=100&only_recruiting=0&only_eligible=0&only_active=0Umbilical Vessel Catheterization Under ECG Monitoring ...
Our study aims at using a more non-invasive means of placing and continuously monitoring catheter placement using superficial electrocardiogram ...
Umbilical Vein Catheterization - StatPearls - NCBI Bookshelf
Umbilical vein catheterization can provide a safe and effective route for intravenous delivery of medications and fluids during resuscitation. This activity ...
4.
publications.aap.org
publications.aap.org/pediatrics/article/145/Supplement_3/S243/34470/Selection-and-Insertion-of-Vascular-Access-DevicesSelection and Insertion of Vascular Access Devices in ...
This systematic review provides the first synthesis of the breadth of evidence available for the selection and insertion of VADs in ...
Umbilical Vessel Catheterization Under ECG Monitoring ...
Our study aims at using a more non-invasive means of placing and continuously monitoring catheter placement using superficial electrocardiogram ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.